Eslicarbazepine acetate: its effectiveness as adjunctive therapy in clinical trials and open studies.
about
Safety Profile of Eslicarbazepine Acetate as Add-On Therapy in Adults with Refractory Focal-Onset Seizures: From Clinical Studies to 6 Years of Post-Marketing Experience.Eslicarbazepine acetate in epilepsies with focal and secondary generalised seizures: systematic review of current evidence.Postmarketing experience with brivaracetam in the treatment of epilepsies: A multicenter cohort study from Germany.Pooled efficacy and safety of eslicarbazepine acetate as add-on treatment in patients with focal-onset seizures: Data from four double-blind placebo-controlled pivotal phase III clinical studies.Selecting Rational Drug Combinations in Epilepsy.
P2860
Eslicarbazepine acetate: its effectiveness as adjunctive therapy in clinical trials and open studies.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 18 January 2017
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Eslicarbazepine acetate: its e ...... nical trials and open studies.
@en
Eslicarbazepine acetate: its e ...... nical trials and open studies.
@nl
type
label
Eslicarbazepine acetate: its e ...... nical trials and open studies.
@en
Eslicarbazepine acetate: its e ...... nical trials and open studies.
@nl
prefLabel
Eslicarbazepine acetate: its e ...... nical trials and open studies.
@en
Eslicarbazepine acetate: its e ...... nical trials and open studies.
@nl
P2093
P2860
P1433
P1476
Eslicarbazepine acetate: its e ...... inical trials and open studies
@en
P2093
B J Steinhoff
E Ben-Menachem
M Holtkamp
P2860
P2888
P304
P356
10.1007/S00415-016-8338-2
P577
2017-01-18T00:00:00Z